A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism
Ceramides are signalling molecules that regulate several physiological functions including insulin sensitivity. Here the authors report a selective ceramide synthase 1 inhibitor that counteracts lipid accumulation within the muscle and adiposity by increasing fatty acid oxidation but without affecti...
Enregistré dans:
Auteurs principaux: | Nigel Turner, Xin Ying Lim, Hamish D. Toop, Brenna Osborne, Amanda E. Brandon, Elysha N. Taylor, Corrine E. Fiveash, Hemna Govindaraju, Jonathan D. Teo, Holly P. McEwen, Timothy A. Couttas, Stephen M. Butler, Abhirup Das, Greg M. Kowalski, Clinton R. Bruce, Kyle L. Hoehn, Thomas Fath, Carsten Schmitz-Peiffer, Gregory J. Cooney, Magdalene K. Montgomery, Jonathan C. Morris, Anthony S. Don |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b889316af6b04ac29b1836b3ff8bcb97 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
par: Linda R. Peterson, et autres
Publié: (2018) -
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities
par: Melania Gaggini, et autres
Publié: (2021) -
Ceramide structure dictates glycosphingolipid nanodomain assembly and function
par: Senthil Arumugam, et autres
Publié: (2021) -
Ceramides bind VDAC2 to trigger mitochondrial apoptosis
par: Shashank Dadsena, et autres
Publié: (2019) -
Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia
par: Anna I. Tkachev, et autres
Publié: (2021)